Delving into the Latest Updates on Nanjing Xianhui Pharmaceutical Engineering Research Institute Co., Ltd. with Synapse

Overview

Tags

Nervous System Diseases

Cardiovascular Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

CD36(Platelet glycoprotein 4)	1

1. 主要目的：评价注射用丹酚酸B单次与多次用于中国健康成人受试者的安全性及耐受性。 2. 次要目的，探索注射用丹酚酸B： (1)皮肤试验方法。 (2)单次与多次用于中国健康成人受试者的药代动力学特征。 (3)单次与多次用于中国健康成人受试者的药效学特征。 (4)单次用于中国健康成人受试者的经肾排泄特征。

[Translation]

1. Primary objective: To evaluate the safety and tolerability of single and multiple administrations of salvianolic acid B for injection in healthy Chinese adult subjects. 2. Secondary objectives: To explore the following aspects: (1) Skin test methods. (2) Pharmacokinetic characteristics of single and multiple administrations in healthy Chinese adult subjects. (3) Pharmacodynamic characteristics of single and multiple administrations in healthy Chinese adult subjects. (4) Renal excretion characteristics of single administration in healthy Chinese adult subjects.

Start Date12 Nov 2019

Sponsor / Collaborator

Nanjing Hongqiao Pharmaceutical Technology Research Institute Co., Ltd.

[+1]

100 Clinical Results associated with Nanjing Xianhui Pharmaceutical Engineering Research Institute Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Nanjing Xianhui Pharmaceutical Engineering Research Institute Co., Ltd.

Login to view more data

100 Deals associated with Nanjing Xianhui Pharmaceutical Engineering Research Institute Co., Ltd.

Login to view more data

100 Translational Medicine associated with Nanjing Xianhui Pharmaceutical Engineering Research Institute Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1 Clinical

1

Login to view more data